uMotif Announces First New Validated Innovation in eCOA/ePRO Since Rolling Out Paper Instruments to Smartphones


“uMotif is the only eCOA/ePRO company that began by working with patients to capture their health and wellness to share with their physicians. Today’s announcement underscores our unique ability to make patient engagement in research easier and more convenient. -CEO Steve Rosenberg

uMotif, one of the fastest growing companies in the clinical trial technology market, continues its transformation of the eCOA/DCT market by announcing that its proprietary Motif data capture interface offers a validated alternative to text-based instruments for clinical, post-marketing and real-world applications. global search.

The industry-leading results are the results of an independent quantitative equivalence study conducted by Willie Muehlhausen (SAFIRA Clinical Research), with testing performed at Dublin City University. Fifty-five participants completed the tests in two randomized groups using the Motif interface and a traditional 5-point Verbal Response Scale (VRS-5). Study results showed equivalence between the Motif interface and a standard VRS (high ICC), demonstrating that the Motif is an equivalent means of capturing VRS data. The equivalence tests were based on the most commonly used PROM – the EQ-5D-5L – which was provided for the study with support from Euroqol. The results of the study are expected to be published in 2023.

The Pattern is a patented flower-shaped graphical user interface. Each petal represents a different issue, such as an outcome measure, symptom, or electronic journal entry. Patients simply slide over each petal to capture their data. The highly visual, easy-to-use interface is faster and more engaging for patients, resulting in higher rates of data entry compliance.

“Over the past 20 years, the clinical research industry has standardized the electronic presentation of traditional data capture widgets like VRS, demonstrating equivalence with paper,” explained Willie Muehlhausen (LinkedIn) of SAFIRA Clinical Research. “The results of this study are exciting, as the Motif is the first new data capture interface since paper instruments were placed on a smartphone. This provides researchers with other ways to engage patients in capturing data through more visually appealing interfaces. »

Putting patients first is in uMotif’s DNA. The company’s experience over the past 10 years has proven that a patient-centric approach is key to delivering effective studies at pace and scale, with unparalleled patient engagement and quality data volumes. . uMotif studies, including the Motif, engaged thousands of participants who captured millions of data points that formed the basis of published research.

uMotif’s highly scalable eCOA/ePRO platform combines deep clinical knowledge and consumer design expertise to deliver unprecedented levels of patient compliance, consistently achieving over 90% compliance in studies worldwide real. uMotif serves the needs of the clinical and RWE market across all countries, languages, therapeutic areas and participant populations, supporting decentralized on-site, hybrid and fully virtual trials. Available on iOS, Android and the web, the uMotif platform supports the most widely used eCOA/ePRO and eDiary input and assessment types.

uMotif CEO Steve Rosenberg (LinkedIn) commented, “uMotif is the only eCOA/ePRO company that began by working with patients to capture their health and wellness to share with their physicians – unlike other other companies that start with the protocol and push the questionnaires. on the patient. We help patients navigate and complete the study by capturing the data needed at each step. Today’s announcement underscores our unique ability to make patient engagement in research easier and more convenient.

About uMotif

The uMotif eCOA/ePRO platform enables faster quality clinical trials by putting participants at the heart of the research. uMotif’s configurable, modular and customizable cloud-native eClinical platform powers fully decentralized site-based clinical, real-life and post-marketing research. For more information visit http://www.umotif.com

Share the article on social networks or by e-mail:

Previous WEB takes you behind the scenes of the music video "Murder Of Crows"
Next Symphonic musicians return to the Westfield Athenaeum for 3 concerts next year